REPORT CASE OF EXCESSIVE GENITAL WARTS, WAD MADANI MATERNITY HOSPITAL
Abstract
Anogenital warts (condylomata acuminata) is the most common viral sexually transmitted disease in the United States. Although condylomata affect both genders, data from office visits for warts obtained from the 1994 to 1998 National Ambulatory Medical Care Survey showed that women accounted for 67 percent of the patient population (1).
References
1. Fleischer, AB Jr, Parrish, CA, Glenn, R, Feldman, SR. Condylomata acuminata (genital warts): Patient demographics and treating physicians. Sex Transm Dis 2001; 28:643.
2. Burk, RD, Kelly, P, Feldman, J, et al. Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis 1996; 23:333.
3. Chua, KL, Hjerpe, A. Persistence of human papillomavirus (HPV) infections preceding cervical cancer. Cancer 1996; 77:121.
4. Klutke, JJ, Bergman, A. Interferon as an adjuvant treatment for genital condyloma acuminatum. Int J Gynaecol Obstet 1995; 49:171.
5. Pfister, H. The role of human papillomaviruses in anogenital cancer. Obstet Gynecol Clin North Am 1996; 23:579.
6. Palefsky, JM. Cutaneous and genital HPV-associated lesions in HIV-infected patients. Clin Dermatol 1997; 15:439.
7. de la, Fuente SG, Ludwig, KA, Mantyh, CR. Preoperative immune status determines anal condyloma recurrence after surgical excision. Dis Colon Rectum 2003; 46:367.
8. Schneider, V, Kay, S, Lee, HM. Immunosuppression as a high-risk factor in the development of condyloma acuminatum and squamous neoplasia of the cervix. Acta Cytol 1983; 27:220.
9. Habel, LA, Van Den, Eeden SK, Sherman, KJ, et al. Risk factors for incident and recurrent condylomata acuminata among women. A population-based study. Sex Transm Dis 1998; 25:285.
10. Van Den, Eeden SK, Habel, LA, Sherman, KJ, et al. Risk factors for incident and recurrent condylomata acuminata among men. A population-based study. Sex Transm Dis 1998; 25:278.
11. Beck, DE, Jaso, RG. Zajac, RA. Surgical management of anal condylomata in the HIV-positive patients. Dis Colon Rectum 1990; 33:180.
12. Conley, LJ, Ellerbrock, TV, Bush, TJ, et al. HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: A prospective cohort study. Lancet 2002; 359:108.
13. Massad, LS, Silverberg, MJ, Springer, G, et al. Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus. Am J Obstet Gynecol 2004; 190:1241.
14. Metcalf, AM, Dean, T. Risk of dysplasia in anal condyloma. Surgery 1995; 118:724.
15. Nadal, SR. Calore, EE. Manzione, CR, et al. Hypertrophic herpes simplex simulating anal neoplasia in aIDS patients: report of five cases. Dis Colon Rectum 2005; 48:2289.
16. ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Number 61, April 2005. Human papillomavirus. Obstet Gynecol 2005; 105:905.
17. Jablonska, S. Traditional therapies for the treatment of condylomata acuminata (genital warts). Australas J Dermatol 1998; 39 Suppl
2. Burk, RD, Kelly, P, Feldman, J, et al. Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis 1996; 23:333.
3. Chua, KL, Hjerpe, A. Persistence of human papillomavirus (HPV) infections preceding cervical cancer. Cancer 1996; 77:121.
4. Klutke, JJ, Bergman, A. Interferon as an adjuvant treatment for genital condyloma acuminatum. Int J Gynaecol Obstet 1995; 49:171.
5. Pfister, H. The role of human papillomaviruses in anogenital cancer. Obstet Gynecol Clin North Am 1996; 23:579.
6. Palefsky, JM. Cutaneous and genital HPV-associated lesions in HIV-infected patients. Clin Dermatol 1997; 15:439.
7. de la, Fuente SG, Ludwig, KA, Mantyh, CR. Preoperative immune status determines anal condyloma recurrence after surgical excision. Dis Colon Rectum 2003; 46:367.
8. Schneider, V, Kay, S, Lee, HM. Immunosuppression as a high-risk factor in the development of condyloma acuminatum and squamous neoplasia of the cervix. Acta Cytol 1983; 27:220.
9. Habel, LA, Van Den, Eeden SK, Sherman, KJ, et al. Risk factors for incident and recurrent condylomata acuminata among women. A population-based study. Sex Transm Dis 1998; 25:285.
10. Van Den, Eeden SK, Habel, LA, Sherman, KJ, et al. Risk factors for incident and recurrent condylomata acuminata among men. A population-based study. Sex Transm Dis 1998; 25:278.
11. Beck, DE, Jaso, RG. Zajac, RA. Surgical management of anal condylomata in the HIV-positive patients. Dis Colon Rectum 1990; 33:180.
12. Conley, LJ, Ellerbrock, TV, Bush, TJ, et al. HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: A prospective cohort study. Lancet 2002; 359:108.
13. Massad, LS, Silverberg, MJ, Springer, G, et al. Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus. Am J Obstet Gynecol 2004; 190:1241.
14. Metcalf, AM, Dean, T. Risk of dysplasia in anal condyloma. Surgery 1995; 118:724.
15. Nadal, SR. Calore, EE. Manzione, CR, et al. Hypertrophic herpes simplex simulating anal neoplasia in aIDS patients: report of five cases. Dis Colon Rectum 2005; 48:2289.
16. ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Number 61, April 2005. Human papillomavirus. Obstet Gynecol 2005; 105:905.
17. Jablonska, S. Traditional therapies for the treatment of condylomata acuminata (genital warts). Australas J Dermatol 1998; 39 Suppl
Published
2009-12-01
How to Cite
ALHASSAN, Elhasan Mohamed et al.
REPORT CASE OF EXCESSIVE GENITAL WARTS, WAD MADANI MATERNITY HOSPITAL.
Gezira Journal of Health Sciences, [S.l.], v. 5, n. 2, dec. 2009.
ISSN 1810-5386. Available at: <http://37.60.236.48/index.php/gjhs/article/view/438>. Date accessed: 03 june 2026.
Issue
Section
Articles
